Development of rheumatoid nodules during anti–tumor necrosis factor α therapy with etanercept
Open Access
- 7 March 2002
- journal article
- letter
- Published by Wiley in Arthritis & Rheumatism
- Vol. 46 (3) , 843-844
- https://doi.org/10.1002/art.10096
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Etanercept therapy in children with treatment-resistant uveitisArthritis & Rheumatism, 2001
- Etanercept combined with conventional treatment in Wegener's granulomatosis: A six-month open-label trial to evaluate safetyArthritis & Rheumatism, 2001
- Development of diabetes mellitus during etanercept therapy in a child with systemic-onset juvenile rheumatoid arthritisArthritis & Rheumatism, 2000
- Relation of glenohumeral and acromioclavicular joint destruction in rheumatoid shoulder. A 15 year follow up studyAnnals of the Rheumatic Diseases, 2000
- Pathogenic mechanisms in the rheumatoid nodule: Comparison of proinflammatory cytokine production and cell adhesion molecule expression in rheumatoid nodules and synovial membranes from the same patientArthritis & Rheumatism, 1998
- TUMOUR NECROSIS FACTOR ALPHA PROMOTER GENE POLYMORPHISM IN SARCOIDOSISCytokine, 1997
- Preliminary criteria for clinical remission in rheumatoid arthritisArthritis & Rheumatism, 1981